AU2001268973A1 - Method for using transfectable constructions from luciferase and from the promotor of the human period 1 gene for identifying novel active substances that influence the day/night rhythm and sleep - Google Patents
Method for using transfectable constructions from luciferase and from the promotor of the human period 1 gene for identifying novel active substances that influence the day/night rhythm and sleepInfo
- Publication number
- AU2001268973A1 AU2001268973A1 AU2001268973A AU6897301A AU2001268973A1 AU 2001268973 A1 AU2001268973 A1 AU 2001268973A1 AU 2001268973 A AU2001268973 A AU 2001268973A AU 6897301 A AU6897301 A AU 6897301A AU 2001268973 A1 AU2001268973 A1 AU 2001268973A1
- Authority
- AU
- Australia
- Prior art keywords
- transfectable
- promotor
- luciferase
- sleep
- constructions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 101150084750 1 gene Proteins 0.000 title 1
- 108060001084 Luciferase Proteins 0.000 title 1
- 239000005089 Luciferase Substances 0.000 title 1
- 239000013543 active substance Substances 0.000 title 1
- 238000010276 construction Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 230000033764 rhythmic process Effects 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/204—IL-6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2864—Sleep disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Plant Pathology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10019360.9 | 2000-04-18 | ||
| DE10019360 | 2000-04-18 | ||
| PCT/EP2001/004383 WO2001079539A2 (en) | 2000-04-18 | 2001-04-18 | Method for using transfectable constructions from luciferase and from the promotor of the human period 1 gene for identifying novel active substances that influence the day/night rhythm and sleep |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001268973A1 true AU2001268973A1 (en) | 2001-10-30 |
Family
ID=7639288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001268973A Abandoned AU2001268973A1 (en) | 2000-04-18 | 2001-04-18 | Method for using transfectable constructions from luciferase and from the promotor of the human period 1 gene for identifying novel active substances that influence the day/night rhythm and sleep |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2001268973A1 (en) |
| WO (1) | WO2001079539A2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1248107A3 (en) * | 2001-03-22 | 2002-10-16 | IPF Pharmaceuticals GmbH | Method and device for time-resolved screening |
| CN114306607A (en) * | 2021-12-31 | 2022-04-12 | 中国人民解放军军事科学院军事医学研究院 | Primary cilia regulate biological rhythms and their related applications |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2260763A1 (en) * | 1996-07-18 | 1998-01-29 | The General Hospital Corporation | Melatonin 1a receptor gene regulatory regions and uses thereof |
| WO1999012952A1 (en) * | 1997-09-09 | 1999-03-18 | Research Development Foundation | Mammalian circadian rhythm-like gene |
-
2001
- 2001-04-18 AU AU2001268973A patent/AU2001268973A1/en not_active Abandoned
- 2001-04-18 WO PCT/EP2001/004383 patent/WO2001079539A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001079539A2 (en) | 2001-10-25 |
| WO2001079539A9 (en) | 2003-05-22 |
| WO2001079539A3 (en) | 2002-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0202705A3 (en) | Methods and microorganisms or production of panto-compounds | |
| AU3549697A (en) | Extracting particles produced by the treating of human or animal nails | |
| DE69812784D1 (en) | Composition for the prevention and elimination of plant diseases | |
| AU3622600A (en) | Metalloproteinases and methods of use therefor | |
| AU2058697A (en) | Treatment of sleep disorders | |
| PL313858A1 (en) | Method of making inactive or killing microorganisms | |
| AU7958100A (en) | Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics | |
| AU7222598A (en) | Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants | |
| DE69420229D1 (en) | Pharmaceutical composition for the treatment of AIDS | |
| EP0922387A4 (en) | Method of screening elicitor inducing the production of phytoalexin in rice and rice disease controlling agent containing elicitor as the active ingredient | |
| AU2335597A (en) | Antibacterially active marine algae extracts from the class diatomatae and methods of use | |
| GB9929497D0 (en) | Improved amino acid mixtures for the treatment and/or management of certain diseases | |
| AU2001268973A1 (en) | Method for using transfectable constructions from luciferase and from the promotor of the human period 1 gene for identifying novel active substances that influence the day/night rhythm and sleep | |
| DE69724613D1 (en) | Antimicrobial agents against eukaryotic microorganisms and methods for suppressing the growth of eukaryotic microorganisms using such agents | |
| AU2139097A (en) | Methods of treating or preventing sleep apnea | |
| AU764930C (en) | Plant photoperiod sensitivity gene and use of the same | |
| DE59914312D1 (en) | USE OF HYDROXYPYRIDONE-CONTAINING POWDER PREPARATIONS FOR THE TREATMENT OF SUB-PRESSURE AND PRESSURE DISORDERS | |
| AU7653600A (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis | |
| AU5779798A (en) | Culture unit and method of manufacturing the same | |
| AU6548396A (en) | Methods for selectively killing or inhibiting the growth of cells expressing the waf1 gene | |
| AU1103701A (en) | Glutamate transporter associated proteins and methods of use thereof | |
| AU5419400A (en) | Thienyl-pyrazoles and their use for controlling pests | |
| AU2002343013A1 (en) | Sequence variants of the human growth hormone gene and methods for detection | |
| AU2002366072A1 (en) | Systems and methods relating to determining the desirability of and recording programming events | |
| AU4176200A (en) | Novel genetic suppressor elements and methods of making the same |